Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cureline Molecular Services is a laboratory division of Cureline Group that provides molecular and cell biology services for translational research, precision medicine, and diagnostic development. The business supports biopharma and academic customers with human biospecimen-based research services including tissue processing, DNA/RNA/protein isolation and analysis, primary cell isolation, cell-based assays, 3D histoculture assays, and biomarker discovery and validation. It operates as a service organization rather than a therapeutic product developer, leveraging Cureline’s broader human biospecimen procurement, biobanking, translational histopathology, and proteomics capabilities. The company appears focused on oncology and other disease-area biospecimen research across preclinical and translational programs. Cureline Molecular Services was established in San Diego in 2015 and is presented as part of the broader Cureline Group commercial services organization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cureline Molecular Services.